Skip to main content
. 2016 Oct 25;139(12):3121–3136. doi: 10.1093/brain/aww254

Figure 6.

Figure 6

IL4I1 modulates IFN-γ and IL-17 expression in CNS lesions and splenocytes. (A) Normalized expressions of Ifng, Il17 and Il4 in wild-type (WT, n = 4) and IL4I1-treated (n = 6) spinal cord lesions at 10 dpl by qRT-PCR. (B) Normalized expression of Ifng expression in splenocyte cultures treated with PMA+Ionomycin in the presence or absence of recombinant IL4I1 for 24 h (n = 3 per group) followed by qRT-PCR. (C) Cell death assay in splenocyte cultures treated with PMA+Ionomycin with or without recombinant IL4I1 for 24 h, and assessed by LIVE/DEAD® cell stain kit (n = 8 per group).